Detalles de la búsqueda
1.
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
Proc Natl Acad Sci U S A
; 115(17): E4041-E4050, 2018 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632196
2.
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
J Transl Med
; 17(1): 357, 2019 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31684954
3.
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Am J Respir Crit Care Med
; 198(7): 928-940, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29518341
4.
Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.
J Immunol
; 197(5): 1621-30, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511738
5.
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations.
Am J Respir Crit Care Med
; 194(11): 1403-1412, 2016 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27299180
6.
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.
Oncoimmunology
; 8(1): e1505174, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30546943
7.
TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma.
Clin Cancer Res
; 24(22): 5710-5723, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764856
8.
Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients.
Oncoimmunology
; 5(12): e1255394, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28123901
9.
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer.
PLoS One
; 9(9): e106914, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25238252
10.
The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
Chest
; 146(3): 633-643, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24676429
11.
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
Cancer Res
; 74(3): 705-15, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24366885
12.
Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.
J Exp Clin Cancer Res
; 32: 18, 2013 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23561041
13.
Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.
PLoS One
; 8(2): e52385, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23405064
14.
Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Invest Ophthalmol Vis Sci
; 54(5): 3657-65, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23611989
15.
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
Clin Cancer Res
; 19(15): 4079-91, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23785047
16.
Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.
PLoS One
; 6(9): e24622, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21949734
Resultados
1 -
16
de 16
1
Próxima >
>>